BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6456219)

  • 1. [Investigation on the antimicrobial activity of cefoperazone (author's transl)].
    Primavesi CA
    Immun Infekt; 1981 Jul; 9(4):150-3. PubMed ID: 6456219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
    Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
    Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of sulperazone on multi-resistant strains of bacteria from burn wounds].
    Xu W; Chen X
    Zhonghua Wai Ke Za Zhi; 1995 Jul; 33(7):390-2. PubMed ID: 8565723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
    Welch DF; Matsen JM
    Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
    Ruczkowska J; Dolna I
    Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C; Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
    Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative susceptibility studies of clinically isolated Pseudomonas aeruginosa, Escherichia coli and Klebsiella spp to cefoperazone and cefotaxime.
    Lee YH; Hussain ZA; Choong FP
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(3):299-303. PubMed ID: 2125616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["In vitro" determination of bacterial sensitivity to tobramycin (author's transl)].
    Talon D; Michel-Briand Y
    Pathol Biol (Paris); 1976 Jan; 24(1):25-30. PubMed ID: 817253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
    Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
    Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of cefoperazone alone and in combination with tobramycin against Pseudomonas aeruginosa.
    Pavillard ER; Miles H
    Clin Ther; 1980; 3(Spec Issue):134-8. PubMed ID: 6446387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of synergistic interaction between aztreonam and cefoperazone.
    Borowski J; Zaremba M; Feliński J
    Chemioterapia; 1987 Jun; 6(2 Suppl):109-10. PubMed ID: 3151329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of new beta-lactam antibiotics].
    Cullmann W; Stieglitz M
    Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
    Garcia-Rodriguez JA
    Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.
    Yoshizawa H; Kubota T; Itani H; Minami K; Miwa H; Nishitani Y
    Bioorg Med Chem; 2004 Aug; 12(15):4221-31. PubMed ID: 15246098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.